No profile data available.
Pharmala Biotech Holdings Inc. (MDMA.CN) is a healthcare company in the drug manufacturing contractors industry, based in Vancouver, Canada.
It reported revenue of 605,498 CAD for fiscal year 2025, down 41.5% from fiscal year 2024, and net income of -2.18 million CAD. In Q2 2026 (the quarter ended February 28, 2026) revenue was 280,584 CAD, up 92.6% from a year before. Its market capitalization was 23.49 million CAD as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended August 31, 2025; market data as of October 9, 2026.
, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.
Pharmala Biotech reported 605,498 CAD in revenue for fiscal year 2025, down 41.5% from 1.04 million CAD in fiscal year 2024. In Q2 2026 revenue was 280,584 CAD.
23.49 million CAD as of October 9, 2026.